RAC

2.20%

$1.78 race oncology ltd

Ann: Race releases complete cardio-protection data & video, page-122

First 122 Last

Share
Profile

Follow
IndexInvestor

8,545 Posts.

1403

26/04/23

23:47

Post #: 67468903
Share

Originally posted by Jdlc: ↑

*If* that's true (that the low SP is now considered a commercial risk) then I'd be stunned.

The board took a strategic approach of being 'under the radar' (I'm sure I'm not alone in cringing at the very mention of that phrase).

You cannot attempt to hide in the shadows and then complain when people don't notice you.

The Zantrene science story is compelling (to me at least) yet RACE seem to continue to fall over themselves commercially to avoid sharing good news about it.

Here's a very recent example from the last couple of months; the awarding of the Wolf Prize for Chemistry to a scientist that has published an article on the effectiveness of Zantrene (in its guise as 'CS1').

Previous winners of Wolf Prize awards can be described absolute titans of science; they include names such as Stephen Hawking and Roger Penrose.

I'll give that statement the space it deserves....

If we're no longer under the radar (urgh, there it is again) then am I alone in thinking that award and it's relevance to the Zantrene story should be shouted enthusiastically from the hill-tops? Even if the ASX would not approve such an announcement, surely it warrant coverage on the RACE website or in conversational video?

Investors love to see that kind of validation of any product.

Good luck finding another biotech (or any other product outside of biotech) that has so much credible, independent validation of its utility. You literally 'cannot buy that'.

To me Zantrene's independent validation was, and continues to be, a differentiator.

I could point you to an article on the Race website or to a video where they've talked through the significance of Professor Chuan He's award or of the multiple appearances of 'CS1' in peer-reviewed papers .....except there's none; we must whisper it quietly for fear of others finding out and perhaps wanting a piece of the pie (... and growing the SP with every bite).

I realise this post may upset some, so if I'm being unfair or have missed the memo then I'll be the first to acknowledge it - so help me out, what am I missing?

Expand

The under the radar overseas strategy is a very minor factor in the low SP. And there never was any under the radar strategy within Australia.

By far the main cause of the low SP is that the spectacular results from the open.label Australian and European EMD AML trials are yet to appear.

RAC Price at posting: $1.87 Sentiment: Buy Disclosure: Held
16 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The market's shrugged at China's stimulus measures all year. Why is this one different?

The winners & losers on market if negative gearing were gone

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

There are more pages in this discussion • 115 more messages in this thread...

First 122 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.78		Change -0.040(2.20%)		Mkt cap ! $302.5M

Open	High	Low	Value	Volume
$1.81	$1.82	$1.76	$132.8K	74.40K

Buyers (Bids)

No.	Vol.	Price($)
1	170	$1.77

Sellers (Offers)

Price($)	Vol.	No.
$1.78	2	1

View Market Depth

No.	Vol.	Price($)
2	4000	1.755
3	12714	1.750
1	3000	1.740
1	1405	1.720
4	25414	1.700

Price($)	Vol.	No.
1.780	3781	1
1.830	7500	1
1.840	1000	1
1.850	5222	1
1.880	2351	1

Last trade - 16.10pm 27/09/2024 (20 minute delay)

RAC (ASX) Chart

Ann: Race releases complete cardio-protection data & video, page-122

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The market's shrugged at China's stimulus measures all year. Why is this one different?

The winners & losers on market if negative gearing were gone

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

ACCC seeks Olam divestments before it can buy Namoi Cotton

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Race releases complete cardio-protection data & video, page-122

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The market's shrugged at China's stimulus measures all year. Why is this one different?

The winners & losers on market if negative gearing were gone

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

ACCC seeks Olam divestments before it can buy Namoi Cotton

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News